Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.

GRANDE PHARMACIE DE SAINT SORLIN : revenue, balance sheet and financial ratios

GRANDE PHARMACIE DE SAINT SORLIN is a French company founded 14 years ago, specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé. Based in SAINT-SORLIN-EN-VALLOIRE (26210), this company of category PME shows in 2025 a net income positive of 254 k€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-04-25

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Financial history - GRANDE PHARMACIE DE SAINT SORLIN (SIREN 539055897)
Indicator 2025 2024 2022 2021 2020 2019 2018 2017
Revenue N/C N/C N/C N/C N/C N/C N/C N/C
Net income 253 851 € 237 979 € 383 794 € 195 507 € 93 542 € 131 820 € 112 508 € 184 328 €
EBITDA N/C N/C N/C N/C N/C N/C N/C N/C
Net margin N/C N/C N/C N/C N/C N/C N/C N/C

Revenue and income statement

In 2025, GRANDE PHARMACIE DE SAINT SORLIN generates positive net income of 254 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2017-2025: 184 k€ -> 254 k€.

Net income (2025) ?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax

253 851 €

Loading income statement...

Chart evolution

Show :

Assets

Loading data...

Liabilities

Loading data...

Solvency and debt ratios

The debt ratio (= Financial debt / Equity x 100) stands at 31%. Debt remains under control: the company retains capacity to raise new debt if needed. Financial autonomy (= Equity / Total assets x 100) reaches 62%. This high autonomy means the company finances most of its assets through equity, a sign of strength.

Debt ratio (2025) ?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low
50-100% : Moderate
> 100% : High

31.295%

Financial autonomy (2025) ?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy
20-30% : Average
< 20% : Low

61.552%

Asset age ratio (2025) ?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Interpretation
< 50% : Recent assets
50-70% : Normal wear
> 70% : Aging assets

9.3%

Solvency indicators evolution
GRANDE PHARMACIE DE SAINT SORLIN

Sector positioning

Debt ratio
31.3 2025
2022
2024
2025
Q1: 13.71
Med: 49.76
Q3: 129.07
Good

In 2025, the debt ratio of GRANDE PHARMACIE DE SAINT... (31.30) ranks below the median of the sector. This ratio measures the weight of debt relative to equity. This controlled position reflects prudent management.

Financial autonomy
61.55% 2025
2022
2024
2025
Q1: 33.42%
Med: 53.71%
Q3: 72.08%
Good

In 2025, the financial autonomy of GRANDE PHARMACIE DE SAINT... (61.5%) ranks above the median of the sector. This ratio represents the share of equity in total financing. This comfortable position offers an appreciable safety margin.

Liquidity ratios

The liquidity ratio (= Current assets / Current liabilities) stands at 178.84. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.

Liquidity ratio (2025) ?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good
1-1.5 : Fair
< 1 : Liquidity risk

178.842

Liquidity indicators evolution
GRANDE PHARMACIE DE SAINT SORLIN

Sector positioning

Liquidity ratio
178.84 2025
2022
2024
2025
Q1: 131.03
Med: 182.29
Q3: 258.7
Average +7 pts over 3 years

In 2025, the liquidity ratio of GRANDE PHARMACIE DE SAINT... (178.84) ranks below the median of the sector. This ratio measures the ability to cover short-term debt with current assets. An improvement would strengthen the competitive position.

Positioning of GRANDE PHARMACIE DE SAINT SORLIN in its sector

Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé

Valuation estimate

Based on 277 transactions of similar company sales in 2025, the value of GRANDE PHARMACIE DE SAINT SORLIN is estimated at 4 032 453 € (range 2 736 441€ - 6 327 474€). This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.

Estimated enterprise value 2025
277 transactions
2736k€ 4032k€ 6327k€
4 032 453 € Range: 2 736 441€ - 6 327 474€
NAF 5 année 2025

Valuation method used

Net Income Multiple
253 851 € × 15.9x = 4 032 453 €
Range: 2 736 442€ - 6 327 475€

Only this financial indicator is available for this company.

Valuation evolution

How is this estimate calculated?

This estimate is based on the analysis of 277 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.

  • EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
  • Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
  • Net Income Multiple: Relevant for mature companies with stable results.

This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).

Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)

Compare GRANDE PHARMACIE DE SAINT SORLIN with other companies in the same sector:

Voir toutes les statistiques du secteur Commerce de détail de produits pharmaceutiques en magasin spécialisé

Frequently asked questions about GRANDE PHARMACIE DE SAINT SORLIN

What is the revenue of GRANDE PHARMACIE DE SAINT SORLIN ?

The revenue of GRANDE PHARMACIE DE SAINT SORLIN is not publicly disclosed (confidential accounts filed with INPI).

Is GRANDE PHARMACIE DE SAINT SORLIN profitable?

Yes, GRANDE PHARMACIE DE SAINT SORLIN generated a net profit of 254 k€ in 2025.

Where is the headquarters of GRANDE PHARMACIE DE SAINT SORLIN ?

The headquarters of GRANDE PHARMACIE DE SAINT SORLIN is located in SAINT-SORLIN-EN-VALLOIRE (26210), in the department Drome.

Where to find the tax return of GRANDE PHARMACIE DE SAINT SORLIN ?

The tax return of GRANDE PHARMACIE DE SAINT SORLIN is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does GRANDE PHARMACIE DE SAINT SORLIN operate?

GRANDE PHARMACIE DE SAINT SORLIN operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.